candesartan has been researched along with metoprolol in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Demers, C; McKelvie, RS; Negassa, A; Yusuf, S | 1 |
| Afzal, R; Held, P; Maggioni, AP; McKelvie, RS; Rouleau, JL; White, M; Young, JB; Yusuf, S | 1 |
| Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
| Adams, V; Dorenkamp, M; Du, J; Noutsias, M; Pauschinger, M; Riad, A; Schultheiss, HP; Spillmann, F; Stiehl, S; Tschöpe, C; Westermann, D | 1 |
| Burnier, M; Wuerzner, G | 1 |
| Boersma, E; Danser, AH; Karamermer, Y; Mattace Raso, FU; Moltzer, E; Roos-Hesselink, JW; Simoons, ML; van den Meiracker, AH; Webb, GD | 1 |
| Angeloni, E; Benedetto, U; di Bartolomeo, R; Melina, G; Refice, S; Roscitano, A; Sinatra, R | 1 |
| Gobburu, J; Jadhav, P; Liu, J; Wang, Y | 1 |
| Bachmann, HS; Besser, M; Severing, AL; Stuermer, EK; Terberger, N | 1 |
| Lauder, L; Mahfoud, F; Meyer, MR; Vollmer, AC; Wagmann, L | 1 |
| Tchernev, G | 1 |
2 review(s) available for candesartan and metoprolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Effects of selective angiotensin II and beta1-receptor blockade on renal haemodynamics and sodium handling during orthostatic stress in healthy individuals.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Heart Failure; Humans; Kidney; Lower Body Negative Pressure; Metoprolol; Renal Circulation; Sodium; Tetrazoles | 2006 |
4 trial(s) available for candesartan and metoprolol
| Article | Year |
|---|---|
Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Therapy, Combination; Enalapril; Exercise Test; Female; Health Status; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Pilot Projects; Quality of Life; Reproducibility of Results; Sickness Impact Profile; Stroke Volume; Surveys and Questionnaires; Tetrazoles; Treatment Outcome; Ventricular Function, Left; Walking | 2001 |
Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiac Volume; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Stroke Volume; Survival Analysis; Tetrazoles; Treatment Outcome; Ventricular Remodeling | 2003 |
Comparison of Candesartan versus Metoprolol for treatment of systemic hypertension after repaired aortic coarctation.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II Type 1 Receptor Blockers; Aortic Coarctation; Benzimidazoles; Biphenyl Compounds; Cohort Studies; Cross-Over Studies; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Peptide Hormones; Tetrazoles; Treatment Outcome; Young Adult | 2010 |
Dual renin-angiotensin system blockade for patients with prosthesis-patient mismatch.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aortic Valve Stenosis; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Female; Follow-Up Studies; Heart Valve Prosthesis; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Male; Metoprolol; Prosthesis Design; Prosthesis Failure; Ramipril; Renin-Angiotensin System; Retrospective Studies; Tetrazoles; Treatment Outcome | 2010 |
9 other study(ies) available for candesartan and metoprolol
| Article | Year |
|---|---|
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
Protection against oxidative stress in diabetic rats: role of angiotensin AT(1) receptor and beta 1-adrenoceptor antagonism.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Experimental; Disease Models, Animal; Hindlimb; Intercellular Adhesion Molecule-1; Male; Membrane Transport Proteins; Metoprolol; Muscle, Skeletal; NADPH Oxidases; Oxidative Stress; Phosphoproteins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Regional Blood Flow; RNA, Messenger; Tetrazoles; Vascular Cell Adhesion Molecule-1; Vasodilation | 2005 |
Improper selection of a pre-specified primary dose-response analysis delays regulatory drug approval.
Topics: Adolescent; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Child; Clinical Protocols; Computer Simulation; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Approval; Drug Dosage Calculations; Endpoint Determination; Humans; Linear Models; Metoprolol; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Sample Size; Tetrazoles; Treatment Outcome | 2013 |
Side Effects of Frequently Used Antihypertensive Drugs on Wound Healing in vitro.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Cell Line; Cell Movement; Diuretics; Fibroblasts; Humans; Hydrochlorothiazide; Keratinocytes; Metoprolol; Ramipril; Tetrazoles; Wound Healing | 2019 |
Assessing Adherence to Antihypertensive Medication by Means of Dose-Dependent Reference Plasma Concentration Ranges and Ultra-High Performance Liquid Chromatography-Ion Trap Mass Spectrometry Analysis.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Body Fluids; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Hypertension; Imidazoles; Liquid-Liquid Extraction; Metoprolol; Patient Compliance; Pilot Projects; Plasma; Reference Values; Reproducibility of Results; Tandem Mass Spectrometry; Tetrazoles | 2021 |
THE NITROSAMINE CONTAMINATION IN BETA BLOCKERS (BISOPROLOL/METOPROLOL), ACE INHIBITORS (LISINOPRIL/PERINDOPRIL), THIAZIDES DIURETICS (HCT), CALCIUM CHANNEL BLOCKERS (AMLODIPINE/FELODIPINE), SARTANS (CANDESARTAN) AND ТHE SUBSEQUENT SKIN CANCER DEVELOPMENT
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Felodipine; Humans; Lisinopril; Melanoma; Metoprolol; Nitrosamines; Perindopril; Prospective Studies; Skin Neoplasms; Sodium Chloride Symporter Inhibitors; Thiazides | 2023 |